Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- A Multi-Ctr Phase III Opn-Lbl Controlled Study Evaluating the Effic and Safety of 0.1 Mmol/Kg Omniscan (Gadodiamide)
- A Multi-Ctr,Rndmzd,Dbl-Bl,Plcb-Cntrl Stdy to Eval the Effic and Saf of Ad5fgf-4 in Patients with Stable Angina
- A Multi-Dsciplinary Approach to Sustainability and Profitability of US Blueberry Production Using the Tree-Like Species
- A Multi-Institutional Phased II Study of Radiation and Gw572016 (Lapatinib) for Patients With Stage III-IV Head and Neck C
- A Multi-Institutional Study to Evaluate the Use of Virtual Patients to Teach and Assess Clinical Skills
- A Multi-Institutional Study to Evaluate the Use of Virtual Patients to Teach and Assess Clinical Skills
- A Multi-Phase Computational Fluid Dynamics (Cfd) Model of a Stormceptor for Seperation of Particulate Matter in Rainfall
- A Multi-Scale Investigation of Liquid-Solid-Gas Interactions
- A Multi-Species/Habitat Ecological Evaluation of Alternativeeverglades Restoration Plans
- A Multicente, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of Bms.....
- A Multicenter Double Blind Placebo Controlled Study of Ora Vescent Fentanyl Citrate for the Treatment of Breakthrough
- A multicenter double blind randomized parallel-group placebo controlled study to investigate the antihypertensive efficacy and safety of Losartan in African Americans with mild to moderate hypertension
- A Multicenter Double Blind Randomized Study Evaluating De Novo Weekly and Once Every 2 Week Darbepoetin Alfa Dosing.....
- A Multicenter Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study the Three Fixed Doses of Aripiprazole I
- A Multicenter Double-Blinded Study in Non Cirrhotic Patients with Chronic Hepatitis C Who Are Non-Responders To Prior Interferon Alfa or Interferon Alfa + Ribavirin Therapy, Comparing Treatment With Thymosin Alpha 1 + Peginterferon Alfa-2a With Peginterferon Alfa-2a + Placebo
- A Multicenter Double-Blinded Study in Patients with Compensated Cirrhosis due to Chronic Hepatitis C Who Are Non-Responders To Prior Interferon Alfa or Interferon Alfa + Ribavirin Therapy, Comparing Treatment With Thymosin Alpha 1 + Peginterferon Alfa-2a With Peginterferon Alfa-2a + Placebo
- A Multicenter Long Term Open Label Study to Access the Safet& Tolerability of Aripiprazole As Adjunctive Therpy.....
- A Multicenter Observational Open Label Single Arm Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis in ..
- A Multicenter Open Label Randomized Duration Finding Study to Investigate the Safety Tolerability Pharmacokinetics......
- A Multicenter Open Label Single Arm Phase 3B Study of Macitentan in Patients With Pulmonary Hypertension To....
- A Multicenter Open-label Extension Study to Assess Long-Term Safety of PF-00547659 in Subjects with Crohn’s Disease OPERA II
- A Multicenter Open-Label, Randomized Phase 1B/2, Study of Brutons Tyrosine Kinase (Btk) Inhibitor, Ibrutinib, in Comb
- A Multicenter Open-Label, Randomized Study to Compare the Safety and Efficacy of Intravenous Ceftolozane/Tazobactam
- A Multicenter Prospective Phase I Study to Evaluate the Safety of Enterprise Assisted Recanalization in Acute Ischemic..
- A Multicenter Randomized Double Blind Placebo Controlled Study of the Human Anit-Tnf Monoclonal Antibody Adalimumab.....
- A Multicenter Randomized Double Blind Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing...
- A Multicenter Randomized Double Masked Parallel-Group Study Evaluatying the Efficacy and Safety of Cyclosporine.........
- A Multicenter Randomized Double-Blind, Placebocontrolled Phase III Study to Evalute the Efficay Safety and ...
- A Multicenter Randomized, Parallel-Group, Double-Blind, Phase III Comparison of the Efficacy and Safety of Questions
- A Multicenter Study Comparing the Ex-Express Mini Glaucoma Shunt to Trabeculectomy in Subjects With Open Angle.........